Systematic review of the toxicity of short-course oral corticosteroids in children

Fahad Aljebab, Imti Choonara, Sharon Conroy, Fahad Aljebab, Imti Choonara, Sharon Conroy

Abstract

Background: Short-course oral corticosteroids are commonly used in children but are known to be associated with adverse drug reactions (ADRs). This review aimed to identify the most common and serious ADRs and to determine their relative risk levels.

Methods: A literature search of EMBASE, MEDLINE, International Pharmaceutical Abstracts, CINAHL, Cochrane Library and PubMed was performed with no language restrictions to identify studies in which oral corticosteroids were administered to patients aged 28 days to 18 years of age for up to and including 14 days of treatment. Each database was searched from their earliest dates to December 2013. All studies providing clear information on ADRs were included.

Results: Thirty-eight studies including 22 randomised controlled trials (RCTs) met the inclusion criteria. The studies involved a total of 3200 children in whom 850 ADRs were reported. The three most frequent ADRs were vomiting, behavioural changes and sleep disturbance, with respective incidence rates of 5.4%, 4.7% and 4.3% of patients assessed for these ADRs. Infection was one of the most serious ADRs; one child died after contracting varicella zoster. When measured, 144 of 369 patients showed increased blood pressure; 21 of 75 patients showed weight gain; and biochemical hypothalamic-pituitary-adrenal axis suppression was detected in 43 of 53 patients.

Conclusions: Vomiting, behavioural changes and sleep disturbance were the most frequent ADRs seen when short-course oral corticosteroids were given to children. Increased susceptibility to infection was the most serious ADR.

Trial registration number: CRD42014008774. By PROSPERO International prospective register of systematic reviews.

Keywords: General Paediatrics; Paediatric Practice; Pharmacology; Therapeutics.

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Figures

Figure 1
Figure 1
Flow chart of the literature search performed.
Figure 2
Figure 2
Relative risk of hypothalamic–pituitary–adrenal axis suppression: oral prednisolone and inhaled corticosteroids.
Figure 3
Figure 3
Relative risk of vomiting: prednisolone (base) tablet or syrup and dexamethasone.

References

    1. British Thoracic Society/Scottish Intercollegiate Guidelines Network. British Guideline on the Management of Asthma 2014.
    1. Douglas G, Higgins B, Barnes N, et al. . British Guideline on the Management of Asthma. Thorax 2008;63(Suppl 4):71.
    1. Loke YK, Price D, Herxheimer A. Systematic reviews of adverse effects: framework for a structured approach. BMC Med Res Methodol 2007;7:32 10.1186/1471-2288-7-32
    1. Egunsola O, Adefurin A, Fakis A, et al. . Safety of fluconazole in paediatrics: a systematic review. Eur J Clin Pharmacol 2013;69:1211–21. 10.1007/s00228-012-1468-2
    1. Kastner M, Wilczynski NL, Walker-Dilks C, et al. . Age-specific search strategies for Medline. J Med Internet Res 2006;8:e25 10.2196/jmir.8.4.e25
    1. Higgins JPT, Altman DG, Gøtzsche PC, et al. . The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928.
    1. von Elm E, Altman DG, Egger M, et al. . Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 2007;335:806–8. 10.1136/
    1. Maund E, Craig D, Suekarran S, et al. . Management of frozen shoulder: a systematic review and cost-effectiveness analysis. Health Technol Assess 2012;16:1–264. 10.3310/hta16110
    1. Scarfone RJ, Loiselle JM, Wiley JF, et al. . Nebulized dexamethasone versus oral prednisone in the emergency treatment of asthmatic children. Ann Emerg Med 1995;26:480–6.
    1. Gordon S, Tompkins T, Dayan PS. Randomized trial of single-dose intramuscular dexamethasone compared with prednisolone for children with acute asthma. Pediatr Emerg Care 2007;23:521–7. 10.1097/PEC.0b013e318128f821
    1. Greenberg RA, Kerby G, Roosevelt GE. A comparison of oral dexamethasone with oral prednisone in pediatric asthma exacerbations treated in the emergency department. Clin Pediatr (Phila) 2008;47:817–23. 10.1177/0009922808316988
    1. Becker JM, Arora A, Scarfone RJ, et al. . Oral versus intravenous corticosteroids in children hospitalized with asthma. J Allergy Clin Immunol 1999;103:586–90.
    1. Rittichier KK, Ledwith CA. Outpatient treatment of moderate croup with dexamethasone: intramuscular versus oral dosing. Pediatrics 2000;106:1344–8.
    1. Qureshi F, Zaritsky A, Poirier MP. Comparative efficacy of oral dexamethasone versus oral prednisone in acute pediatric asthma. J Pediatr 2001;139:20–6. 10.1067/mpd.2001.115021
    1. Altamimi S, Robertson G, Jastaniah W, et al. . Single-dose oral dexamethasone in the emergency management of children with exacerbations of mild to moderate asthma. Pediatr Emerg Care 2006;22:786–93. 10.1097/01.pec.0000248683.09895.08
    1. Manjra AI, Price J, Lenney W, et al. . Efficacy of nebulized fluticasone propionate compared with oral prednisolone in children with an acute exacerbation of asthma. Respir Med 2000;94:1206–14. 10.1053/rmed.2000.0952
    1. Volovitz B, Bentur L, Finkelstein Y, et al. . Effectiveness and safety of inhaled corticosteroids in controlling acute asthma attacks in children who were treated in the emergency department: a controlled comparative study with oral prednisolone. J Allergy Clin Immunol 1998;102:605–9.
    1. Price J, Lenney W, Duncan C, et al. . HPA-axis effects of nebulised fluticasone propionate compared with oral prednisolone in childhood asthma. Respir Med 2002;96:625–31.
    1. Kokron CM, Castro AS, Solé D, et al. . Lysine-vasopressin in the evaluation of the hypothalamic-pituitary-adrenal axis in children with allergic rhinitis treated with intranasal beclomethasone dipropionate or oral prednisone. J Investig Allergol Clin Immunol 1997;7:51–6.
    1. Wolthers OD, Riis BJ, Pedersen S. Bone turnover in asthmatic children treated with oral prednisolone or inhaled budesonide. Pediatr Pulmonol 1993;16:341–6.
    1. Orta-Sibu N, Chantler C, Bewick M, et al. . Comparison of high-dose intravenous methylprednisolone with low-dose oral prednisolone in acute renal allograft rejection in children. Br Med J (Clin Res Ed) 1982;285:258–60.
    1. Kim MK, Yen K, Redman RL, et al. . Vomiting of liquid corticosteroids in children with asthma. Pediatr Emerg Care 2006;22:397–401. 10.1097/01.pec.0000221338.44798.6a
    1. Kayani S, Shannon DC. Adverse behavioral effects of treatment for acute exacerbation of asthma in children: a comparison of two doses of oral steroids. Chest 2002;122:624–8.
    1. Chang AB, Clark R, Sloots TP, et al. . A 5- versus 3-day course of oral corticosteroids for children with asthma exacerbations who are not hospitalised: a randomised controlled trial. Med J Aust 2008;189:306–10.
    1. Schuh S, Coates AL, Dick P, et al. . A single versus multiple doses of dexamethasone in infants wheezing for the first time. Pediatr Pulmonol 2008;43:844–50. 10.1002/ppul.20845
    1. Scarfone RJ, Fuchs SM, Nager AL, et al. . Controlled trial of oral prednisone in the emergency department treatment of children with acute asthma. Pediatrics 1993;92:513–8.
    1. Panickar J, Lakhanpaul M, Lambert PC, et al. . Oral prednisolone for preschool children with acute virus-induced wheezing. N Engl J Med 2009;360:329–38. 10.1056/NEJMoa0804897
    1. Corneli HM, Zorc JJ, Mahajan P, et al. . A multicenter, randomized, controlled trial of dexamethasone for bronchiolitis. N Engl J Med 2007;357:331–9. 10.1056/NEJMoa071255
    1. Tam DT, Ngoc TV, Tien NT, et al. . Effects of short-course oral corticosteroid therapy in early dengue infection in Vietnamese patients: a randomized, placebo-controlled trial. Clin Infect Dis 2012;55:1216–24. 10.1093/cid/cis655
    1. Lux AL, Edwards SW, Hancock E, et al. . The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial. Lancet 2004;364:1773–8. 10.1016/S0140-6736(04)17400-X
    1. Dawson KP, Penna C, Penna AC. Tolerance and compliance of oral prednisolone therapy during acute childhood asthma. Aust J Hosp Pharm 1992;22:278–82.
    1. Hall AS, Thorley G, Houtman PN. The effects of corticosteroids on behavior in children with nephrotic syndrome. Pediatr Nephrol 2003;18:1220–3. 10.1007/s00467-003-1295-x
    1. Vallance K, Liu W, Mandrell BN, et al. . Mechanisms of dexamethasone-induced disturbed sleep and fatigue in paediatric patients receiving treatment for ALL. Eur J Cancer 2010;46:1848–55. 10.1016/j.ejca.2010.03.026
    1. Ailakis JG, Hope ME, Stafford L, et al. . Comparison of paediatric steroid mixtures. Aust J Hosp Pharm 1998;28:246–9.
    1. Francisca AH, Linus HP, Alejandro MA. Función Suprarrenal en Pacientes con Síndrome Bronquial Obstructivo Tratados con Corticoides Sistémicos (Informe Preliminar). Rev Chil Pediatr 2009;80:347–53.
    1. Zora JA, Zimmerman D, Carey TL, et al. . Hypothalamic-pituitary-adrenal axis suppression after short-term, high-dose glucocorticoid therapy in children with asthma. J Allergy Clin Immunol 1986;77:9–13.
    1. Suarez CR, Rademaker D, Hasson A, et al. . High-dose steroids in childhood acute idiopathic thrombocytopenia purpura. Am J Pediatr Hematol Oncol 1986;8:111–15.
    1. de Sousa NG, Santa-Marta C, Morais-Almeida M. Systemic corticosteroid hypersensitivity in children. J Investig Allergol Clin Immunol 2010;20:529–32.
    1. Kasper WJ, Howe PM. Fatal varicella after a single course of corticosteroids. Pediatr Infect Dis J 1990;9:729–32.
    1. Feder HM, LaRussa P, Steinberg S, et al. . Clinical varicella following varicella vaccination: don't be fooled. Pediatrics 1997;99:897–9.
    1. Wu C-T, Tsai S-C, Lin J-J, et al. . Disseminated varicella infection in a child receiving short-term steroids for asthma. Pediatr Dermatol 2008;25:484–6. 10.1111/j.1525-1470.2008.00720.x
    1. Dawson KL, Carter ER. A steroid-induced acute psychosis in a child with asthma. Pediatr Pulmonol 1998;26:362–4.
    1. Lew DB, Higgins GC, Skinner RB, et al. . Adverse reaction to prednisone in a patient with systemic lupus erythematosus. Pediatr Dermatol 1999;16:146–50.
    1. Counts SJ, Baylink DJ, Shen FH, et al. . Vitamin D intoxication in an anephric child. Ann Intern Med 1975;82:196–200.
    1. Brito PN, Silva SE, Cotta JS, et al. . Severe ocular hypertension secondary to systemic corticosteroid treatment in a child with nephrotic syndrome. Clin Ophthalmol 2012;6:1675–9. 10.2147/OPTH.S36261
    1. Ularntinon S, Tzuang D, Dahl G, et al. . Concurrent treatment of steroid-related mood and psychotic symptoms with risperidone. Pediatrics 2010;125:e1241–5. 10.1542/peds.2009-1815
    1. Streck WF, Lockwood DH. Pituitary adrenal recovery following short-term suppression with corticosteroids. Am J Med 1979;66:910–14.
    1. Hawcutt DB, Jorgensen AL, Wallin N, et al. . Adrenal responses to a low-dose short synacthen test in children with asthma. Clin Endocrinol (Oxf) 2015;82:648–56. 10.1111/cen.12655
    1. Brown ES, Beard L, Frol AB, et al. . Effect of two prednisone exposures on mood and declarative memory. Neurobiol Learn Mem 2006;86:28–34. 10.1016/j.nlm.2005.12.009

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel